Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

452

HTML

3372

Figures (1-2)

194

Tables (1-1)

162

Sum=4180

Feb 28, 2008 (publication date) through May 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 28, 2008; 14(8): 1159-1166
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1159

Figure 1 Mechanism of PC development.

Open in New Tab Full Size Figure Download Figure

Figure 2 Rationale of CRS plus IPHC in treating PC.

Citation: al-Shammaa HAH, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 2008; 14(8): 1159-1166
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1159.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1159